Monoclonal Antibody Treatment

Monoclonal Antibody Treatment

Monoclonal antibody treatment for COVID-19 may block the virus that causes COVID-19 from attaching to human cells, making it more difficult for the virus to reproduce and cause harm. Monoclonal antibodies may also neutralize a virus. Eligible to high-risk individuals who have tested positive for COVID within the last 10 days.

Why do patients need it?

Patients who are defined under high-risk criteria should consider Monoclonal Antibody Treatment since it is an extra layer of protection to keep you from getting especially sick from the virus. These high-risk categories include:


  • Older age
  • Obesity or being overweight  
  • Pregnancy
  • Chronic kidney disease
  • Diabetes
  • Immunosuppressive disease or immunosuppressive treatment
  • Cardiovascular disease (including congenital heart disease) or hypertension
  • Chronic lung diseases (for example, chronic obstructive pulmonary disease, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis and pulmonary hypertension)
  • Sickle cell disease
  • Neurodevelopmental disorders (for example, cerebral palsy) or other conditions that confer medical complexity (for example, genetic or metabolic syndromes and severe congenital anomalies)
  • Having a medical-related technological dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID 19))


Patient Instructions:

Does not require fasting.


*Must have insurance

How It Works

Your Guide to Prism Health Lab

Decide your services.

Book an appointment.

See a medical specialist.

Receive your results!

Patients Also Purchased